Mahsaw Mansoor, Noor-Us-Sabah Ahmad, S Bilal Ahmed, Samuel Tadros, James Folk, Michael D Abramoff
{"title":"Sterile Caliper Anterior Chamber Decompression Mitigates Intraocular Pressure Spikes in Intravitreal Injections.","authors":"Mahsaw Mansoor, Noor-Us-Sabah Ahmad, S Bilal Ahmed, Samuel Tadros, James Folk, Michael D Abramoff","doi":"10.1167/tvst.13.12.13","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the efficacy of a novel approach using a sterile caliper for anterior chamber (AC) decompression in reducing post-intravitreal injection (IVI) intraocular pressure (IOP) spikes.</p><p><strong>Methods: </strong>A prospective interventional case series conducted at the Iowa City Veterans Affairs Medical Center (VAMC) with Institutional Review Board approval. Patients were randomized to receive conventional IVI or IVI with sterile caliper decompression. Fifty eyes from 47 patients underwent IVI for various retinal pathologies. Subjects were randomly assigned to the intervention or control arm. Two resident physician providers performed injections, with one applying sterile caliper decompression (intervention) and the other following the standard technique (control). Baseline and postinjection IOP were measured using Tonopen (Reichert, Depew, NY).</p><p><strong>Results: </strong>In both groups there was a significant IOP rise following IVI (P < 0.0001). There was no significant difference in baseline IOP between groups (P = 0.082), but postinjection IOP was significantly lower in the intervention group (23.52 ± 5.98 mm Hg) compared to the control group (44.08 ± 8.48 mm Hg). There were no patients with an IOP spike >25 mm Hg in the intervention arm. The technique was effective regardless of lens status.</p><p><strong>Conclusions: </strong>Sterile caliper AC decompression significantly reduced post-IVI IOP spikes presenting an efficient and cost-effective alternative to previously proposed methods of IOP reduction. Further studies are warranted to validate these findings and explore broader applications in ophthalmic interventions.</p><p><strong>Translational relevance: </strong>The caliper decompression technique presents potential benefit in preventing short-term morbidity associated with IOP spikes after IVI and addressing long-term concerns in patients with pre-existing glaucoma.</p>","PeriodicalId":23322,"journal":{"name":"Translational Vision Science & Technology","volume":"13 12","pages":"13"},"PeriodicalIF":2.6000,"publicationDate":"2024-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11636662/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational Vision Science & Technology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1167/tvst.13.12.13","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: To investigate the efficacy of a novel approach using a sterile caliper for anterior chamber (AC) decompression in reducing post-intravitreal injection (IVI) intraocular pressure (IOP) spikes.
Methods: A prospective interventional case series conducted at the Iowa City Veterans Affairs Medical Center (VAMC) with Institutional Review Board approval. Patients were randomized to receive conventional IVI or IVI with sterile caliper decompression. Fifty eyes from 47 patients underwent IVI for various retinal pathologies. Subjects were randomly assigned to the intervention or control arm. Two resident physician providers performed injections, with one applying sterile caliper decompression (intervention) and the other following the standard technique (control). Baseline and postinjection IOP were measured using Tonopen (Reichert, Depew, NY).
Results: In both groups there was a significant IOP rise following IVI (P < 0.0001). There was no significant difference in baseline IOP between groups (P = 0.082), but postinjection IOP was significantly lower in the intervention group (23.52 ± 5.98 mm Hg) compared to the control group (44.08 ± 8.48 mm Hg). There were no patients with an IOP spike >25 mm Hg in the intervention arm. The technique was effective regardless of lens status.
Conclusions: Sterile caliper AC decompression significantly reduced post-IVI IOP spikes presenting an efficient and cost-effective alternative to previously proposed methods of IOP reduction. Further studies are warranted to validate these findings and explore broader applications in ophthalmic interventions.
Translational relevance: The caliper decompression technique presents potential benefit in preventing short-term morbidity associated with IOP spikes after IVI and addressing long-term concerns in patients with pre-existing glaucoma.
目的:探讨一种使用无菌卡尺进行前房(AC)减压的新方法在降低玻璃体内注射(IVI)后眼压(IOP)峰值中的疗效。方法:经机构审查委员会批准,在爱荷华市退伍军人事务医学中心(VAMC)进行前瞻性介入病例系列研究。患者随机接受常规IVI或无菌卡钳减压的IVI。47例患者50只眼因各种视网膜病变行静脉注射。受试者被随机分配到干预组或对照组。两名住院医师进行注射,一名采用无菌卡尺减压(干预),另一名采用标准技术(对照)。使用Tonopen (Reichert, Depew, NY)测量基线和注射后IOP。结果:两组IVI术后IOP均显著升高(P < 0.0001)。两组患者基线IOP差异无统计学意义(P = 0.082),但干预组注射后IOP(23.52±5.98 mm Hg)明显低于对照组(44.08±8.48 mm Hg)。干预组无患者眼压峰值超过25 mm Hg。无论晶状体状态如何,该技术都是有效的。结论:无菌卡钳AC减压术可显著降低ivi后IOP尖峰,是一种有效且经济的IOP降低方法。需要进一步的研究来验证这些发现,并探索眼科干预的更广泛应用。翻译相关性:卡钳减压技术在预防IVI后与IOP尖峰相关的短期发病率和解决已有青光眼患者的长期问题方面具有潜在的益处。
期刊介绍:
Translational Vision Science & Technology (TVST), an official journal of the Association for Research in Vision and Ophthalmology (ARVO), an international organization whose purpose is to advance research worldwide into understanding the visual system and preventing, treating and curing its disorders, is an online, open access, peer-reviewed journal emphasizing multidisciplinary research that bridges the gap between basic research and clinical care. A highly qualified and diverse group of Associate Editors and Editorial Board Members is led by Editor-in-Chief Marco Zarbin, MD, PhD, FARVO.
The journal covers a broad spectrum of work, including but not limited to:
Applications of stem cell technology for regenerative medicine,
Development of new animal models of human diseases,
Tissue bioengineering,
Chemical engineering to improve virus-based gene delivery,
Nanotechnology for drug delivery,
Design and synthesis of artificial extracellular matrices,
Development of a true microsurgical operating environment,
Refining data analysis algorithms to improve in vivo imaging technology,
Results of Phase 1 clinical trials,
Reverse translational ("bedside to bench") research.
TVST seeks manuscripts from scientists and clinicians with diverse backgrounds ranging from basic chemistry to ophthalmic surgery that will advance or change the way we understand and/or treat vision-threatening diseases. TVST encourages the use of color, multimedia, hyperlinks, program code and other digital enhancements.